Dr. Reddy’s announces the launch of Ibandronate Sodium tablets

02 Jul 2012

1

Hyderabad-based Dr Reddy's Laboratories today said that it has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market on June 29, 2012 following the approval by the USFDA of Dr. Reddy's ANDA for Ibandronate sodium tablets.

 The Boniva brand and generic had US sales of approximately $486 million for the last 12 months ending March 2012 according to IMS Health.

 Dr. Reddy's Ibandronate sodium tablets in 150 mg are available in cartons of 3 blister packs containing 1 tablet each (once monthly dosing).

Boniva is a prescription medication used to treat or prevent osteoporosis in women after menopause, and is manufactured by GlaxoSmithKline and Roche Holding AG. The drug has been linked to side effects, for which it faced lawsuits in 2009.

In 2007, Roche had filed lawsuits against Dr Reddy's, which had filed for FDA approval for its version of Boniva, but Roche claimed the drug was covered by one patent or another through 2023.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more